|
VPS4B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.65039999999417E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.968400E-02 |
| Normal-vs-Stage2 |
3.851800E-02 |
| Normal-vs-Stage3 |
1.53839999994521E-06 |
| Normal-vs-Stage4 |
1.06960000001433E-06 |
| Stage1-vs-Stage2 |
3.131400E-01 |
| Stage1-vs-Stage3 |
2.184300E-04 |
| Stage1-vs-Stage4 |
1.575770E-04 |
| Stage2-vs-Stage3 |
1.708580E-01 |
| Stage2-vs-Stage4 |
7.887700E-02 |
| Stage3-vs-Stage4 |
5.643000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.248400E-04 |
| Normal-vs-AfricanAmerican |
3.87809999999877E-05 |
| Normal-vs-Asian |
2.162000E-01 |
| Caucasian-vs-AfricanAmerican |
9.356200E-02 |
| Caucasian-vs-Asian |
9.561600E-01 |
| AfricanAmerican-vs-Asian |
4.548600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.77349999999077E-05 |
| Normal-vs-Female |
1.438470E-02 |
| Male-vs-Female |
4.676200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.139600E-03 |
| Normal-vs-Age(41-60Yrs) |
6.204400E-03 |
| Normal-vs-Age(61-80Yrs) |
8.1821000000093E-05 |
| Normal-vs-Age(81-100Yrs) |
3.958500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.994000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.038000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.247000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.151950E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.964800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.897400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.991800E-01 |
| Normal-vs-Grade 2 |
1.956590E-01 |
| Normal-vs-Grade 3 |
5.51419999994529E-07 |
| Normal-vs-Grade 4 |
1.01929997775585E-09 |
| Grade 1-vs-Grade 2 |
2.013400E-01 |
| Grade 1-vs-Grade 3 |
7.038700E-04 |
| Grade 1-vs-Grade 4 |
2.22489999999187E-05 |
| Grade 2-vs-Grade 3 |
1.52029999999082E-05 |
| Grade 2-vs-Grade 4 |
1.71820000449685E-08 |
| Grade 3-vs-Grade 4 |
1.001950E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.167800E-01 |
| Normal-vs-ccB subtype |
4.31479999507545E-08 |
| ccA subtype-vs-ccB subtype |
3.51629947381582E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.768000E-04 |
| Normal-vs-N1 |
7.036300E-02 |
| N0-vs-N1 |
4.856600E-01 |
|
|
